Cargando…

Effect of oral anticoagulants on the outcome of faecal immunochemical test

BACKGROUND: We aimed to evaluate whether oral anticoagulants (OACs) alter faecal immunochemical test (FIT) performance in average-risk colorectal cancer (CRC) screening. METHODS: Individuals aged 50–69 years were invited to receive one FIT sample (cutoff 75 ng ml(–1)) between November 2008 and June...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bujanda, L, Sarasqueta, C, Lanas, Á, Quintero, E, Cubiella, J, Hernandez, V, Morillas, J D, Perez-Fernández, T, Salas, D, Andreu, M, Carballo, F, Bessa, X, Portillo, I, Jover, R, Balaguer, F, Cosme, A, Castells, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950875/ https://www.ncbi.nlm.nih.gov/pubmed/24496455 http://dx.doi.org/10.1038/bjc.2014.38

Ejemplares similares

Impact of the faecal immunochemical test on colorectal cancer survival
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Colorectal Cancer Survival in 50- to 69-Year-Olds after Introducing the Faecal Immunochemical Test
por: Gutierrez-Stampa, María Angeles, et al.
Publicado: (2020)

Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study
por: Herrero, Jesús-Miguel, et al.
Publicado: (2018)

Faecal immunochemical test outside colorectal cancer screening?
por: Pin-Vieito, Noel, et al.
Publicado: (2021)

Optimal diagnostic accuracy of quantitative faecal immunochemical test positivity thresholds for colorectal cancer detection in primary health care: A community‐based cohort study
por: Pin‐Vieito, Noel, et al.
Publicado: (2021)

High-risk symptoms and quantitative faecal immunochemical test accuracy: Systematic review and meta-analysis
por: Pin Vieito, Noel, et al.
Publicado: (2019)

Faecal Immunochemical Test Impact on Prognosis of Colorectal Cancer Detected in Symptomatic Patients
por: Fernández de Castro, Jesús Daniel, et al.
Publicado: (2022)

Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients
por: Cubiella, Joaquín, et al.
Publicado: (2016)

Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test
por: Pin-Vieito, Noel, et al.
Publicado: (2020)

Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test
por: Otero-Estévez, O, et al.
Publicado: (2015)

Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Gerrard, A D, et al.
Publicado: (2023)

Accuracy of faecal immunochemical testing in patients with symptomatic colorectal cancer
por: Khan, A. A., et al.
Publicado: (2020)

Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia
por: Wong, Sunny H, et al.
Publicado: (2017)

Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2019)

Faecal Haemoglobin Estimated by Faecal Immunochemical Tests—An Indicator of Systemic Inflammation with Real Clinical Potential
por: Barnett, Karen N., et al.
Publicado: (2021)

Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study
por: Quintero, Enrique, et al.
Publicado: (2016)

Faecal immunochemical testing in the COVID-19 era: balancing risk and costs
por: Arasaradnam, Ramesh P, et al.
Publicado: (2020)

Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
por: Arana-Arri, Eunate, et al.
Publicado: (2017)

Varying faecal immunochemical test positivity thresholds impacts colorectal cancer detection
por: White, P, et al.
Publicado: (2023)

Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme
por: Digby, Jayne, et al.
Publicado: (2023)

Guaiac and immunochemical tests for faecal occult blood in colorectal cancer screening.
por: Castiglione, G., et al.
Publicado: (1992)

Faecal immunochemical testing (FIT) in symptomatic patients: what are we missing?
por: Farrugia, Alexia, et al.
Publicado: (2019)

Faecal immunochemical test: challenges and opportunities for cancer diagnosis in primary care
por: Craig, Mary, et al.
Publicado: (2022)

FIT for colonoscopy: Benefits of the faecal immunochemical test for triaging symptomatic patients
por: Symonds, Erin L., et al.
Publicado: (2022)

Service evaluation of faecal immunochemical testing and anaemia for risk stratification in the 2‐week‐wait pathway for colorectal cancer
por: Chapman, C., et al.
Publicado: (2019)

Evaluation of Alpha 1-Antitrypsin and the Levels of mRNA Expression of Matrix Metalloproteinase 7, Urokinase Type Plasminogen Activator Receptor and COX-2 for the Diagnosis of Colorectal Cancer
por: Bujanda, Luis, et al.
Publicado: (2013)

Faecal immunochemical test for suspected colorectal cancer symptoms: patient survey of usability and acceptability
por: Georgiou Delisle, Theo, et al.
Publicado: (2022)

Faecal immunochemical testing in bowel cancer screening: Estimating outcomes for different diagnostic policies
por: Li, Shuping J, et al.
Publicado: (2020)

Screening uptake of colonoscopy versus fecal immunochemical testing in first-degree relatives of patients with non-syndromic colorectal cancer: A multicenter, open-label, parallel-group, randomized trial (ParCoFit study)
por: González-López, Natalia, et al.
Publicado: (2023)

Sociodemographic variations in the uptake of faecal immunochemical tests in primary care: a retrospective study
por: Bailey, James A, et al.
Publicado: (2023)

Faecal immunochemical testing implementation to increase colorectal cancer screening in primary care
por: Bakhai, Smita, et al.
Publicado: (2018)

Faecal immunochemical test-based colorectal cancer screening in Mexico: an initial experience
por: Remes-Troche, José María, et al.
Publicado: (2020)

Prevalence of repeat faecal immunochemical testing in symptomatic patients attending primary care
por: Johnstone, Mark S., et al.
Publicado: (2022)

Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Chong, Yuki, et al.
Publicado: (2023)

Risk of missing colorectal cancer with a COVID-adapted diagnostic pathway using quantitative faecal immunochemical testing
por: Maeda, Y, et al.
Publicado: (2021)

Implementation of a mailed faecal immunochemical test programme for colorectal cancer screening among Veterans
por: Deeds, Stefanie Ann, et al.
Publicado: (2022)

Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas
por: Gallardo-Gómez, María, et al.
Publicado: (2023)

Author response to: Comment on: Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer
por: Gerrard, Adam D, et al.
Publicado: (2023)

Faecal haemoglobin concentration thresholds for reassurance and urgent investigation for colorectal cancer based on a faecal immunochemical test in symptomatic patients in primary care
por: Mowat, Craig, et al.
Publicado: (2021)

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
por: Goede, S Lucas, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qkh9tir48uuijvjn34jpd3pa2h